BioCentury | Jun 12, 2006
Company News

RecombinoGen management update

RecombinoGen Ltd. , Guildford, U.K. Business: Infectious Promoted: Stephen Wrigley to CEO from CTO WIR Staff...
BioCentury | Jun 7, 2006
Company News

RecombinoGen names Wrigley CEO

...Infectious disease company RecombinoGen (Guildford, U.K.) promoted Stephen Wrigley to CEO from chief technical officer. BC Staff...
BioCentury | Nov 7, 2005
Company News

RecombinoGen management update

RecombinoGen Ltd. , Guildford, U.K. Business: Infectious Hired: Stephen Wrigley as CTO, formerly senior director of research at Cubist Pharmaceuticals Inc.'s Cubist Pharmaceuticals (U.K.) Ltd. Unit WIR Staff Infectious...
BioCentury | Sep 26, 2005
Emerging Company Profile

Corporate Profile

RecombinoGen Ltd. Guildford, U.K. Technology: High Frequency Recombination Disease focus: Infectious Clinical status: Research Founded: 2004 by Colin Smith, Joanne Neary, John Jim and Matthew Borg University collaborators: None Corporate partners: None Number of employees:...
BioCentury | Sep 26, 2005
Emerging Company Profile

RecombinoGen: Recombinatorial biosynthesis

...for ways to discover new compounds or get the bugs to make innovative semi-synthetic drugs. RecombinoGen Ltd....
...corresponds to the generated amino acid sequence in the peptide product. Colin Smith, founder of RecombinoGen...
...might be a challenge applying HFR directly within industrially used streptomycetes," he said. Part of RecombinoGen's...
BioCentury | Jun 9, 1997
Emerging Company Profile

Maxygen: Evolution of DNA in vitro; Zaffaroni's enabling focus

Maxygen: Evolution of DNA in vitro Recombinant DNA techniques are the unquestioned foundation of biotechnology. Maxygen Inc. hopes to take this technology to a new level, combining DNA recombination plus mutation (to generate maximal diversity)...
Items per page:
1 - 6 of 6
BioCentury | Jun 12, 2006
Company News

RecombinoGen management update

RecombinoGen Ltd. , Guildford, U.K. Business: Infectious Promoted: Stephen Wrigley to CEO from CTO WIR Staff...
BioCentury | Jun 7, 2006
Company News

RecombinoGen names Wrigley CEO

...Infectious disease company RecombinoGen (Guildford, U.K.) promoted Stephen Wrigley to CEO from chief technical officer. BC Staff...
BioCentury | Nov 7, 2005
Company News

RecombinoGen management update

RecombinoGen Ltd. , Guildford, U.K. Business: Infectious Hired: Stephen Wrigley as CTO, formerly senior director of research at Cubist Pharmaceuticals Inc.'s Cubist Pharmaceuticals (U.K.) Ltd. Unit WIR Staff Infectious...
BioCentury | Sep 26, 2005
Emerging Company Profile

Corporate Profile

RecombinoGen Ltd. Guildford, U.K. Technology: High Frequency Recombination Disease focus: Infectious Clinical status: Research Founded: 2004 by Colin Smith, Joanne Neary, John Jim and Matthew Borg University collaborators: None Corporate partners: None Number of employees:...
BioCentury | Sep 26, 2005
Emerging Company Profile

RecombinoGen: Recombinatorial biosynthesis

...for ways to discover new compounds or get the bugs to make innovative semi-synthetic drugs. RecombinoGen Ltd....
...corresponds to the generated amino acid sequence in the peptide product. Colin Smith, founder of RecombinoGen...
...might be a challenge applying HFR directly within industrially used streptomycetes," he said. Part of RecombinoGen's...
BioCentury | Jun 9, 1997
Emerging Company Profile

Maxygen: Evolution of DNA in vitro; Zaffaroni's enabling focus

Maxygen: Evolution of DNA in vitro Recombinant DNA techniques are the unquestioned foundation of biotechnology. Maxygen Inc. hopes to take this technology to a new level, combining DNA recombination plus mutation (to generate maximal diversity)...
Items per page:
1 - 6 of 6